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Choline deficiency, via  deprivation of labile  methyl 
groups,  is  associated  with a greatly  increased  incidence 
of hepatocarcinoma in  experimental animals. This di- 
etary deficiency also  causes fatty  liver, because  choline 
is needed for hepatic  secretion of lipoproteins. We hy- 
pothesized that  fatty  liver might be associated with  the 
accumulation of 1,2-sn-diradylglycerol  and  subse- 
quent  activation of protein  kinase C. Several  lines of 
evidence  indicate that  cancers might  develop second- 
ary to  abnormalities  in  protein  kinase  C-mediated  sig- 
nal transduction. We observed that rats fed a choline- 
deficient diet for 1, 6, or 27 weeks had increased 
hepatic  concentrations of 1,2-diradylglycerol. At 1 and 
6 weeks,  hepatic  plasma  membrane  from  choline-de- 
ficient rats had increased concentrations of 1,2-sn- 
diacylglycerol and 1-alkyl, 2-acylglycerol, with the 
latter accounting for 20-26% of membrane 1,2-sn- 
diradylglycerol  (as  compared  with  only 2-5% in con- 
trols).  Protein  kinase C  activity  was  increased in he- 
patic plasma membrane at 1 week of choline defi- 
ciency. By Western  blotting  there  was  an  increase  in 
the amount of protein  kinase  C 5 and a  decrease in  the 
amount of protein  kinase  C 6 in  liver  at 1 week.  By 6 
weeks of choline  deficiency,  hepatic  plasma  membrane 
and cytosolic protein  kinase  C (PKC) activities  were 
increased  significantly,  with  increased  amounts of he- 
patic plasma  membrane  protein  kinase  C a, and 6 de- 
tected by Western  blotting. Glycogen synthase  activity 
in liver  was  diminished after 1 week of choline  defi- 
ciency; this enzyme is inhibited by PKC-mediated 
phosphorylation. We suggest that choline deficiency 
perturbed PKC-mediated transmembrane  signaling 
within  liver  and  that  this  contributed  to  the develop- 
ment of hepatic  cancer in these  animals. 
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Choline is the major dietary source for labile methyl groups 
(Zeisel, 1988) and  its metabolism is inter-related with methi- 
onine and folate metabolism; choline deficiency depletes all 
of these methyl donors (Pomfret et al., 1990; Selhub et al., 
1991;  Zeisel et al., 1989). Choline is the only single nutrient 
for which dietary deficiency is associated with development 
of foci of premalignant hepatocytes (which express y-glutamyl 
transpeptidase  and the placental form of glutathione S-trans- 
ferase (Shinozuka and Lombardi, 1980; Takahashi et al., 
1979)) and with the subsequent development of hepatocarci- 
nomas in the absence of any known carcinogen (Chandar  and 
Lombardi, 1988; Mikol et al., 1983; Newberne and Rogers, 
1986). 
Due to  the inability to form phosphatidylcholine, a  constit- 
uent of the lipoprotein envelope, secretion of triglyceride 
(TG)’ is inhibited in choline deficiency (Yao and Vance,  1988, 
1989), causing lipid to accumulate (Lombardi, 1971; Lombardi 
et al., 1968; Yao and Vance, 1988). In addition to massive 
accumulation of TG, we have observed the accumulation of 
1,2-sn-diradylglycerol (DRG) within liver during choline de- 
ficiency (Blusztajn and Zeisel,  1989). DRG is an  intermediate 
for the biosynthesis of TG and membrane phospholipids. 
DRG  is also a second messenger, formed when plasma mem- 
brane receptors for certain hormones, neurotransmitters, or 
growth factors are coupled to phospholipases (Blackshear et 
al., 1988; Exton, 1988). The DRG molecule remains within 
the membrane after hydrolysis of phospholipids and can ac- 
tivate  a regulatory enzyme, protein kinase C (PKC), by facil- 
itating the enzyme’s translocation from cytosol to plasma 
membrane (Nishizuka, 1986). There  are at least 10 isoforms 
of PKC encoded by at least six distinct genes;  only a, 6, and 
{ isoforms have  been identified in liver (Wetsel et al., 1992). 
The predominant components of DRG in tissues are the ester- 
linked 1,2-diacyl (DAG) species, and the 1-alkyl-2-acyl glyc- 
erols (AAG; ether-linked  1-0-alkyl-2-acyl  and vinyl-linked 1- 
0-alk-l’-enyl-Z-acyl species). These subclasses of DRG  may 
differ in  their ability to activate  PKC (Bass et al., 1989; Cabot 
and  Jaken, 1984; Daniel et al., 1988;  Dawson and Cook,  1987; 
Ford et al., 1989; Heymans et al., 1987). The targets for 
phosphorylation by PKC have not been completely described, 
but  they include receptors for insulin, epidermal growth fac- 
tor,  and many proteins involved in control of  gene expression, 
The abbreviations used are: TG, triglyceride; DRG, 1,2-sn-dira- 
dylglycerol; PKC, protein kinase C;  DAG, 1,2-diacylglycerol; AAG, 1- 
alkyl-2-acyl glycerols; TPCK, n-tosyl-L-phenylalanine chloromethyl 
ketone; CHAPSO, 3-[3-cholamidopropyl)dimethylammonio]-2-hy- 
droxy-1-propanesulfonic acid BSA, bovine serum albumin; PBS, 
phosphate-buffered saline. 
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cell division, and  differentiation  (Nishizuka, 1986; Weinstein, 
1990). The appearance of DRG in membranes is usually 
transient, and therefore PKC is activated for only a short 
time  after a  receptor has been stimulated  (Price et al., 1989). 
In  choline-deficient  liver, chronic  accumulation of DRG could 
result  in prolonged activation of PKC.  We now report  upon 
the subcellular distribution  and subclasses of DRG  in liver 
during choline deficiency and upon the increase in PKC 
protein  and  activity  within  these livers. 
MATERIALS AND  METHODS 
Animal Care-Animal care was in accordance with institutional 
guidelines of the University of North Carolina at Chapel Hill. Male 
Fischer 344 rats (90 g; Charles River Breeders, Wilmington, MA) 
were housed in an isolated room in stainless steel hanging cages and 
were exposed to light for 12 h/day. They were fed a semipurified 
choline sufficient or choline-deficient. diet (contained 0.2% methio- 
nine, 0.005 g/kg folate, 0.003 g/kg vitamin B12; sufficient diet con- 
tained 0.46% choline, deficient diet contained 0.006% choline by our 
assay; Lombardi Choline Diets, Dyets, Bethlehem, PA) for 1, 6, or 27 
weeks. Water was offered ad libitum. Animals were anesthetized with 
ether, and a sample of liver was collected and chilled on ice for 
immediate use in subcellular fractionation and Western blotting. A 
lobe of liver  was also collected by freeze-clamping with tongs cooled 
in liquid nitrogen and was stored at -80 "C until used for phospho- 
choline and glycogen synthase assays. 
Subcellular Fractionation-Weighed aliquots (2 g) of the fresh 
livers were homogenized in a cold sucrose buffer (0.25 M;  ultracen- 
trifugation grade, Fisher)  containing 20 mM Tris, 0.5 mM EGTA, 2 
mM EDTA, 2 mM MgCI,, 0.1% aprotinin, 20 p M  leupeptin, 0.1 mM 
n-tosyl-t-phenylalanine chloromethyl ketone (TPCK), 5 mM dithio- 
threitol, 1 mM phenylmethylsulfonyl fluoride (Sigma), pH 8.0. The 
lipid layer on top was aspirated off and saved, and subcellular frac- 
tions were prepared (Aronson and Touster, 1974). Marker enzymes 
were assayed in all fractions and were used to check purity of the 
following fractions: delipidated cytosol (lactate dehydrogenase (Ca- 
baud and Wroblewski, 1958)), mitochondria + lysosomal pellet (suc- 
cinate dehydrogenase (Pennington, 1961), and acid phosphatase (An- 
dersch and Szczypinski, 1947)), plasma membrane from microsomal 
pellet (5'-nucleotidase (Dixon and Purdom, 1954)), endoplasmic re- 
ticulum (glucose 6-phosphatase (Aronson and Touster, 1974)). Purity 
of nuclei and of lipid droplets was determined by measuring DNA 
(Labarca and Paigen, 1980), and TG (Tacconi and  Wurtman, 1985), 
respectively. The cytosol, plasma membrane, nuclei and lipid frac- 
tions had < 2% contamination with any of the other  fractions based 
upon measurements of the marker enzymes. 
Lipid Analyses-Lipids  were extracted from liver and subcellular 
fractions of liver using the method of Bligh and Dyer (1959). Hepatic 
T G  was isolated by thin layer chromatography, hydrolyzed, and 
measured as methyl esters using capillary gas chromatography (Tac- 
coni and Wurtman, 1985). Triheptadecanoin (C17:O; Nu Chek Prep, 
Elysian, MN) was  used as an  internal standard  to correct for varia- 
tions in recovery.  DRG  was determined using diacylglycerol kinase 
(Lipidex, Westfield, NJ) and [32P]ATP (Amersham Corp.) to form 
radiolabeled phosphatidic acid (Preiss et al., 1986), which  was isolated 
by thin layer chromatography (CHC13/MeOH/acetic acid, 65:15:5), 
and quantitated using an imaging radiometric scanner (Bioscan, 
Washington, DC). This assay is specific for 1,2-sn-diradylglycerol 
and will not detect other isomers nor TG. AAG was determined by 
converting the total diradylglycerol to [3ZP]phosphatidic acid using 
diacylglycerol kinase according to Preiss et al. (1986) and  then adding 
500 units of Rhizopus lipase (Sigma) for 30 min at  37 "C to destroy 
the DAG present (Tyagi et al., 1989). The radiolabeled phosphatidic 
acid was then quantitated as described earlier. Amounts of  AAG  were 
calculated by comparison with analyses of authentic  standard 
synthesized from l-O-alkyl-2-oleoyl-sn-glycero-3-phosphocholine 
(Avanti Polar Lipids, Alabaster, AL) using phospholipase C  (Blank 
et al., 1984; Mavis et al., 1972) and purified with a C18 cartridge (Sep- 
pak; Waters Associates, Milford, MA). DAG was determined as  the 
difference between total DRG and AAG measurements. Diacylglyc- 
erol kinase and  [32P]ATP will react with ceramide (Turinsky  et al., 
1990) to form a  phosphorylatedproduct that was completely separated 
from [32P]diradylphosphatidate during thin layer chromatography. 
We believe that  the addition of protease inhibitors (0.1% aprotinin, 
20 p M  leupeptin, 0.1 mM TPCK, 1 mM phenylmethylsulfonyl fluoride) 
a t  the start of membrane preparation prevented artifactual formation 
of DRG during subcellular fractionation. DRG concentrations were 
lower in plasma membrane preparations (6-week animals) that were 
prepared in  the presence of the protease inhibitors as compared with 
membrane prepared from liver without the inhibitors (36% lower in 
controls, 49% lower in deficients; p < 0.01 by t test).  The addition of 
protease inhibitors at  the end of plasma membrane preparation did 
not prevent increased DRG concentrations. Thus, we concluded that 
one or more of these  inhibitors prevented phospholipid breakdown 
and that protease inhibitors should be added when DRG is to be 
measured in subcellular fractions. 
The lipid droplets in the choline-deficient livers contained more 
than 1000 times more TG than DRG. If lipid droplets contaminated 
subcellular fractions during preparation, then the TG content of 
fractions would provide an upper bound to the amount of such 
contamination. Using the DRG/TG ratio in the droplets of deficient 
liver (0.001 at 1 week,  0.0005 at 6 weeks,  0.0006 at 27 weeks), and the 
TG concentrations measured in the plasma membrane fraction, we 
found that  an insignificant amount of the DRG in plasma membrane 
could have come from contamination by lipid droplets (Table I). 
Thus, the hepatic DRG concentrations in plasma membrane were 
not  an  artifact of TG contamination from the lipid droplets. Cytosol, 
from which the  fat layer had been removed after low speed centrifu- 
gation, was examined in  a similar manner  (Table I). In  this fraction, 
most of the DRG could have come from lipid droplets. In  another 
experiment, we determined whether DRG that was associated with 
lipid droplets might have been shifted to plasma membrane during 
subcellular fractionation, we took the lipid layer from 6 week choline- 
deficient liver and mixed it with the homogenate of liver  from control 
rats. There was no difference between  DRG concentrations in plasma 
membrane prepared from control liver or from control liver with 
added fat layer (10.4 f 0.7 and 10.6 It 0.3 nmol/mg of protein, 
respectively). Protein  in samples used for DRG measurements was 
determined using a colorimetric assay (Bradford, 1976). 
Protein Kinase C Assay and Western  Blotting-Total homogenate, 
delipidated cytosol, and plasma membrane from microsomal pellet 
were prepared and PKC activity was assayed by measuring the 
transfer of [32P]phosphate from [T-~'P]ATP  to histone H1 by a slight 
modification of the method of Kikkawa et al. (1983). The samples 
were solubilized with 1% Nonidet P-40  and kept overnight at -80 "C 
to increase solubilization and maximize activity. They were thawed 
and incubated on ice with 1% CHAPSO (Sigma). After sonicating 
with 10 1-s pulses (setting 7;  model  W225R, Heat Systems Ultrason- 
ics, Plainview, NJ),  the samples were applied to a DEAE-cellulose 
column (Sigma) equilibrated with Buffer A (20 mM Tris-HCI, 2 mM 
sodium EDTA, 0.5 mM EGTA at pH 7.5). Columns were washed 
twice with 0.5 ml of Buffer A. The PKC was eluted with 0.45  ml  of 
0.15 M NaCl in Buffer A. Assay tubes contained the following in a 
volume of 100 pl: 20 mM Tris-HCI, 1 mM CaC12, 10 mM MgCl,, 500 
gg/ml histone Type 111-S (Sigma), 0.2 mM ATP, and IO6 dpm  [y-"PI 
ATP (Amersham Corp.). The reaction was started with the addition 
of  5-15  pg  of protein of the PKC  preparation. Samples were assayed 
in  triplicate  in the presence and absence of  90  pg  of phosphatidylser- 
ine (Sigma) and 1 p~ phorbol 12-myristate  13-acetate (Sigma). Re- 
actions were incubated for 5 min at 32 "C and stopped by addition of 
0.4  ml  of 20% trichloroacetic acid and 10 p1 of  20 pg/pl  bovine serum 
albumin (BSA; Sigma). Trichloroacetic acid-precipitated protein was 
collected on filter paper with a  Skatron Cell Harvester (Sterling, VA) 
and unincorporated label was  removed  by washing with 7.5% trichlo- 
roacetic acid. Radioactivity of 32P on the filters was determined by 
liquid scintillation counting, and PKC activity was expressed as 
activity in the presence of activators less the activity measured in the 
absence of the phospholipid and phorbol ester activators. Protein was 
determined by the bicinchoninic acid method of Smith et al. (1985). 
In order to determine whether PKC might be associated with lipid 
droplets, we also determined activity in this fraction. Lipids were 
aspirated from the top of the tube after the first centrifugation of the 
subcellular fractionation procedure, and this fraction was washed 
three times with Tris buffer (20 mM, pH 7.5). Nonidet P-40 (1%) was 
added and sample was frozen overnight. Prior to assay, CHAPSO 
(1%) was added and sample sonicated. No PKC activity was associ- 
ated with the lipid droplets once they had been washed. 
An aliquot of liver homogenate (25 pg total protein/lane) was 
subjected to 10% SDS-polyacrylamide gel electrophoresis according 
to the method of Laemmli (Laemmli, 1970). Prestained molecular 
weight markers (Amersham Corp.) were  used as standards for  molec- 
ular mass comparisons: myosin, 200 kDa; phosphorylase b, 97.4 kDa; 
BSA,  69 kDa; ovalbumin, 46 kDa; carbonic anhydrase, 30 kDa; trypsin 
inhibitor, 21.5 kDa; and lysozyme,  14.3  kDa. The separated proteins 
2 102 Choline  Deficiency 
TABLE I 
Triacylgl.vcero1 and 1.2-sn-diradylRlycero1 in p h m a  membrane and cytosol 
Using the DRG/TG concentration  ratio  present the lipid droplets in the liver (0.001 at 1 week;  0.0005 at 6 weeks,  0.0006 at 27 weeks), and 
the TG concentrations measured in the plasma membrane and cytosolic fractions, the possible contamination of  DRG from the lipid droplets 
was calculated in these two fractions from livers of rats fed a choline-deficient diet for 1, 6, and 27 weeks. Percent maximum contamination 









nrnollrng protein nrnollrng protein 
Plasma membrane 1 71 '4 0.07 f 0.002 
128 f 4 0.06 f 0.002 6 
27 191 5 53 0.15 5 0.03 
Cytosol 1 65 2 7 
6 
0.07 ? 0.007 
40 ? 4 0.02 f 0.002 








were transferred by electroblotting (50 min at  400  mA using a semidry 
blotting apparatus; Owl Scientific Plastics, Cambridge, MA) on ni- 
trocellulose paper (pore size, 0.45 pm). Nonspecific binding sites were 
blocked by incubation with 5% nonfat dry milk in 1 X phosphate- 
buffered saline (PRS) for 1 h at room temperature. The nitrocellulose 
sheets were incubated with the respective PKC antisera (a, 6, or j- at 
1:1000 dilution in 1% RSA in 1 X PRS; antibodies were a generous 
gift of Dr. Yusuf A. Hannun, Duke University) for 4 h a t  room 
temperature. These three isozymes were studied because they have 
previously been shown to be the only isozymes of PKC present in 
liver (Wetsel et al., 1992). After five washes with 1 X PRS at 10-min 
intervals, secondary antiserum  (sheep anti-rabbit IgG conjugated with 
alkaline phosphatase, diluted 1:1000 in 1% RSA in 1 X PRS;  Sigma) 
was added and incubated for 2 h a t  room temperature. The above 
washing procedure was repeated, and color was developed using 
bromochloroindoyl phosphate/nitro blue tetrazolium. Density of the 
80-kDa bands were determined by scanning densitometry. 
Glycozen Synthase-Aliquots of frozen liver were  homogenized  in 
cold 0.25 M sucrose, 50 mM Tris, 10 mM EDTA, pH 7.8 (6 volumes/g 
of tissue) and centrifuged for 30 rnin at 16,000 X g and  4 "C. The 
supernatants were collected, and glycogen synthase  activity was as- 
sayed by measuring the incorporation of radioactivity from uridine 
5'-diphospho["C]gIucose (Amersham Corp.) into glycogen (Thomas 
et nl., 1968). Samples were added to  an assay mixture containing 50 
mM Tris, 10 mM EDTA, pH 7.8, 6.7 mM UDP-["C]glucose (0.0s pCi/ 
pmol) and 10 mg/ml rabbit liver glycogen (Sigma) in the presence 
and absence of 6.7 mM glucose 6-phosphate  (Sigma). After incubating 
for 15  min at 30  'C, an aliquot was spotted on filter paper (2  X 2 cm; 
Whatman 31ET, Hillshoro, OR), and the unincorporated label was 
removed with 66% ethanol. Radioactivity of "C on the filters was 
determined by liquid scintillation counting and glycogen synthase 
activity was expressed as the ratio of the activity measured without/ 
with glucose &phosphate. 
I'hosphocholine-Phosphocholine was measured in samples of fro- 
zen liver using the method of Pomfret et al. (1989). 
RESULTS AND DISCUSSION 
When  rats  were  fed a semisynthetic  diet  devoid of choline 
for 1, 6, or 27 weeks, fat accumulated in liver (Fig. 1). T h e  
livers of the control animals were smooth, shiny, and deep 
red  in  color  at  all  the  time  intervals.  However,  the  livers of 
t h e  choline-deficient  animals a t  1 and 6 weeks  were  yellow- 
brown  in  color  with a micronodular  greasy  appearance.  They 
were  also  larger (9.3 k 0.5 g a t  1 week, 13.2 f 0.2 g a t  6 weeks) 
than  the  control  livers (4.9 f 0.2 g at 1 week, 7.5 f 0.3 g at 6 
weeks).  The  choline-deficient  livers at 27 weeks  also  looked 
micronodular,  swollen,  and  pale  brown,  but  their  weights (10.9 
f 0.4 g )  were  not  different  from  control (10.8 f 0.3 g ) .  T h e  
animals gained similar amounts of weight throughout the 
studies  (at 6 and 27 weeks,  controls  gained 103 f 2 g and 273 
f 8 g, respectively;  deficients  gained 104 f 2 g and 275 k 8 g, 
mean k S.E.). These  observations  are  consistent  with  earlier 
studies. 
-...l-._l.. .._ - ...... _ 1 ~  .. ~ - . , . - ," . - . " . . -  ._ . _  .. . 
F[(;, 1. Flistology photos: control, 6-week. nnd 2 7 - w w k  
liver. Slices o f  liver were fixed 111 10' ;  neutral huffcrcd !orrnalln, 
paraffin-embedded. and  stained with hematoxvlln and eosin. Heprc- 
sentative fields are shown from control liver ( A ) ,  fi-week choline- 
deficient liver (R), and 27 week choline-deficient liver (('). S m l ~ ~  bar. 
25  pm for A-C. 
Choline deficiency was verified by showing that hepatic 
concentrations of phosphocholine  were  markedly  diminished 
in  deficient  animals as compared  with  controls.  Phosphocho- 
line  content of liver  has  been  shown  previously to be  a 
sensitive  indicator of choline  deficiency  (Pomfret et al., 1990; 
Zeisel et al., 1989). In our study, at 1 week phosphocholine 
content of liver was 617 nmol/g (+.40) in control rats' liver 
and 37 nmol/g (k3)  in  deficient  rats'  liver.  At 6 weeks, 
phosphocholine content of liver was 906 nmol/g (5.54) in 
control  rats'  liver  and 50 nmol/g (58) in  deficient  rats' liver. 
At  27 weeks,  phosphocholine  content of liver  was 2.273 nmol/ 
g (+.285) in  control  rats'  liver  and 225 nmol/g (224)  in 
deficient rats' liver. 
As  expected,  the  massive  accumulation of lipid  in  liver  was 
largely due to accumulation of TG  (Lombardi  et al . ,  1968). 
Hepatic TG concentrations  in  control  animals  remained  rel- 
atively  constant  during 27 weeks  (approximately 200 nmol/ 
mg  protein).  In  deficient  animals  TG  in  liver  was 941 f 81 a t  
1 week, 1,339 +. 161 a t  6 weeks,  and 646 +. 39 a t  27 weeks (a11 
values p < 0.01 different  from  control  at  same  time  point). 
Hepatic plasma membrane TG was similar in controls and 
deficient  animals  at ll time  points (70-250 nmol/mg  protein). 
In addition to accumulation of TG,  we observed that, in 
livers  from  choline-deficient  animals,  there  was  a  remarkable 
increase  in  DRG  concentrations  (Tables 11,111, and IV) .  DRG 
only increased in plasma membrane and nuclear membrane 
and  not  in  endoplasmic  reticular  membrane.  In  plasma  mem- 
brane,  DRG  reached  values  higher  than  those  occurring  after 
stimulation of a  receptor  linked  to  phospholipase C activation 
(e .g  vasopressin receptor) and of the order of magnitude 
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TABLE I1 
1,2-sn-Diradylglycerol  concentrations in liver from rats  at 1 week on 
experimental  diet 
Rats were fed defined diets  containing choline (Control) or devoid 
of  choline (Deficient) for 1 week. Liver  was  collected and  subcellular 
fractionation was performed  as described under  "Materials  and  Meth- 
ods." DRG was extracted  and assayed. Data  are  expressed as mean -C 
S.E. Statistical differences  were determined using Student's  unpaired 
t test. 
Fraction  Control  Deficient  C trol p value n 
nmollmg protein % 
Homogenate 1.92 t 0.18 6.58 +- 0.41 343 <0.001 6 
Delipidated  cytosol 0.27 f 0.01 0.30 k 0.01 NS" 6 
Plasma  membrane 11.76 f 0.25 17.37 f 0.95 148 <0.001 6 
Nuclei 2.16 f 0.10 5.81 k 0.76 269 <0.001 6 
nmol/liuer 
Liuid droulets 4.1 f 0.5  422 1- 45 10.300 <0.001 6 
' NS,  not significant. 
TABLE 111 
1,2-sn-Dirad.ylglycerol  concentrations i n  liver  from  rats  ut 6 weeks  on 
experimental  diet 
Rats were fed defined diets  containing  choline  (Control) or devoid 
of  choline (Deficient) for 6 weeks. Liver was collected and analyzed 
as in  Table 11. Data  are  expressed  as  mean 1- S.E. Statistical differ- 
ences were determined using Student's  unpaired t test. 











4.56 ? 0.24 10.12 ? 0.92 222 <0.001 6 
0.25 _C 0.02 0.28 f 0.02 NS" 6 
12.21 t 1.55 19.24 C 1.17 158 0.005  6 
2.31 rf: 0.17 2.10 _t 0.29 91 NS 6 
3.09 f 0.60 3.50 f 0.73 113 NS 6 
nmollliuer 
4.4 f 0.7 721 k 30 16,286 <0.001 6 
' NS,  not  significant. 
TABLE IV 
~,Z-sn-Diradylfilycerol  concentrations  in  liver  from  ruts at 27 weeks 
on  experimental  diet 
Rats were fed defined diets  containing  choline  (Control)  or devoid 
of choline (Deficient) for 27 weeks. Liver was collected and analyzed 
as in  Table 11. Data  are expressed as  mean 1- S.E. Statistical differ- 
ences were determined using Student's  unpaired t test. 










nmoljmg protein % 
6.58 f 0.67 13.88 f 1.30 210 <0.001 10 
0.26 k 0.02 0.29 f 0.02 NS" 10 
16.21 f 2.16 14.72 -t 1.85 91 NS 10 
3.22 +- 0.25 2.29 f 0.30 71 NS 10 
1.98 f 0.34 1.52 f 0.41 77 NS 10 
21.1 1- 1.5 612 f 92 2,897 <0.001 10 
nmollliuer 
NS,  not significant. 
needed  to  activate  PKC  in  platelets  and  to modify responses 
t o  &,-adrenergic receptors  in  the liver  (Bocckino et al., 1985; 
Cooper et al., 1985; Kaibuchi et al., 1983; Lapetina et al., 1985; 
Preiss et al., 1986). At all  time  points,  most of total  hepatic 
DRG was present  within  the lipid droplets (see Fig. 1; Tables 
11-IV that  accumulated  in  choline deficiency. AAG in  hepatic 
lipid  droplets from  deficient animals  accounted for 14,20,  and 
18% of total  DRG at 1, 6, and 27 weeks, respectively. 
The  increase  in  plasma  membrane  DRG observed at  1 and 
6 weeks was the  result of increases in both AAG and DAG 
content  (Table V; note  that  these  data  are from  a  replication 
of the  experiment  reported in Tables 11-IV and differ  slightly 
in total DRG present). In control animals, AAG accounted 
for 2-5% of DRG in liver plasma membrane. In deficient 
animals, AAG accounted  for 20-26% at times when DRG was 
elevated (1 and 6 weeks).  Previously, such high concentrations 
of AAG have been mainly observed in  tumor cells (Snyder 
and Snyder, 1975) or in stimulated neutrophils (Bauldry et 
al., 1988). These subclasses of DRG may  differ in  their  ability 
to  activate  PKC. Although AAG has been considered to be 
incapable of activating  PKC  (Cabot  and  Jaken, 1984), recent 
studies  indicate  that  naturally occurring  species of AAG ac- 
tivate  PKC (Dawson and Cook, 1987; Ford et al., 1989). This 
activation may require free  calcium concentrations  found only 
in  stimulated cells (Ford et al., 1989). The alkyl  group  in the 
1-position diminishes  the diglyceride's ability  to  activate  PKC 
relative to the corresponding DAG (Heymans et al., 1987), 
and AAGs with short  chain  fatty acid substituents  appear  to 
be better activators than are those with longer chain fatty 
acids (Bass et al., 1989). 1-0-Alkyl-2-acetyl  analogs of AAG 
inhibit PKC activation by DAG (Daniel et al., 1988). This 
acetyl analog may  differ  from other AAGs in biologic activity; 
Rider et al. (1988)  have speculated  that  the biologic activity 
of AAG may be dependent  on conversion to alkylacetylglycer- 
ophosphocholine (platelet-activating  factor). 
We observed significant  increases  in  PKC  activity associ- 
ated with hepatic  plasma  membranes  (Tables VI-VIII). That 
PKC  increased at 6 weeks in both plasma membranes and 
cytosol (Table  VII) suggests that  there was a stable  activation 
of PKC  and/or  an  increase  in  the  total  PKC pool in  the cell. 
TABLE V 
Subclasses  of  1,2-sn-diradylglycerol i n  liver  plasma  membrane  during 
choline  deficiency 
Rats were treated  as described in  Table 11. Total diradylglycerol 
was determined using  a  radioenzymatic  assay. AAG was determined 
after hydrolysis of diacylglycerol species  using Rhizopus lipase. These 
data  are from  a  replication of the  experiments  reported  in  Tables II- 
IV. DAG was calculated  as  the difference between total diradylgly- 
cero1 and AAG. Data  are  expressed  as  mean f S.E. for n = 6 samples 
per point. Statistical differences were determined using Student's 




Control  Deficie  Control  Deficient 
nmollmg protein nmollmg protein 
1 0.2 f 0.1 3.8 f 1.9" 8.9 f 1.1 10.7 f 1.9 
6 0.4 f 0.2 3.3 f 0.6" 8.9 -t 1.1 12.9 rf: 1.2* 
27 0.4 f 0.3 0.9 +- 0.4 7.5 f 1.0 5.3 1- 0.3 
' p  < 0.01. 
b p  < 0.05. 
TABLE VI 
PKC activity in liver  from  ruts  at 1 week on  experimental  diet 
Rats were fed  defined diets  containing  choline  (Control)  or devoid 
of  choline (Deficient) for 1 week. Liver  was  collected and subcellular 
fractionation was performed  as described under  "Materials  and  Meth- 
ods." PKC activity was measured using  a  radioenzymatic  assay. Data 
are expressed as mean f S.E.  Statistical differences were determined 
using  Student's  unpaired t test. 
Fraction  Control  Deficient  Control p value n 
pmollmg protein X min" % 
Homogenate 1,961 f 305 2,016 k 146 103 NS" 6 
Cytosol 2,419 C 108 2,407 k 88 100 NS 6 
Plasma  membrane 3,373 _t 271 4,998 1- 408 148 0.008 6 
a NS,  not significant. 
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TABLE VI1 
I’KC activity in  liurr  from  rats at 6 rrvrks on r.xpcrirnrntn1 dirt 
Kats were fed defined diets  containing  choline  (Control)  or devoid 
ofcholine  (Deficient) for 6 weeks. Liver  was analyzed as described in 
Table VI. Data are expressed as mean f S.E. Statistical  differences 
were  determined using Student’s  unpaired t test. 
Fraction Control Deficient Control v:ue n 
pmollmg profrin X min” % 
Homogenate 2,765 f 193 9,825 & 394 138 0.036 6 
Cytosol 2,oOz f 36 3,375 f 109 I f 9  0.001 6 
Plasma meml)rane 12,431 -C 742 31,554 f 2.765 254 0.001 6 
TARIX VI11 
PKC actiuity in  liver  from  rats at 27 rr~rrl;.~ on  experimrntnl  dirt 
Rats were led defined diets  containing  choline  (Control)  or devoid 
o f  choline (Delicient) for 27 weeks. Liver was analyzed as descrihed 
in  Tahle VI. Data  are expressed as mean f S.E. Statistical differences 
were determined using Student’s  unpaired t test. 
Fraction Control Deficient Control v:ue n 
pmol/mg protein X min” 7; 
Homogenate 2,261 f 87 2,404 f 191 106 NS” 6 
Cytosol 1,866 f 101 2,194 f 170 118 N S  9 
Plasma memhrane 8,707 f 1,194 14,932 & 1,207 171 0.002 9 
” NS, not signilicant. 
a F 6 
C D   C D   C D  
”-.~ i_ __ - . . 
97 kDa 
69 kDa 1 week 
percent  control 23‘lC’i 2 3 ’ ,  * 32256 + 
.“.T.r”,, ” 1 7 - -.-< . - 
97 kDa 
69 kDa 6 weeks 
percent  cont ol 1 R5% * 950% ’ 263% 
FIG. 2. Protein kinase C isozymes in liver  at 1 week and 6 
weeks on experimental diet,  as assessed  by Western blotting. 
Rats were fed defined diets  containing  choline ( C )  or devoid ofcholine 
( I ) )  for 1 or 6 weeks. l iver was collected and  homogenate  prepared 
as descrihed under “Materials and Methods.” Proteins (25 p g  total 
protein/lane) were analyzed by SDS-polyacrylamide gel electropho- 
resis,  electrohlotted,  and  immunostainetl with anti-protein  kinase  C 
( Y ,  6, or {antihody  as described “Materials  and  Methods.”  Represent- 
nt ive hands  are shown for each isozyme and  hoth  diets.  The  amounts 
o f  I’KC isozymes in deficients expressed as percent  mean  hand 
density as compared  with control  are also presented for all animals 
studied ( n  = :)/point). * = p < 0.05 different from control. 
The  changes  in  membrane-associated  PKC  (Tables VI-VIII) 
t h a t  we observed  might  he  due  to  changes  in  one or more of 
these isoforms. Using Western blotting (Fig. 2), in 1-week 
liver  homogenate, we ohserved  that  amounts of PKC  {were 
increased  (3-fold; p < 0.05), whereas  PKC d decreased (to 23% 
of  control; p < 0.05).  At 6 weeks  (Fig.  2),  amounts of P K C  (Y 
a n d  d were  increased (2- and IO-fold,  respectively; p < 0.05). 
W e  observed  changes  in  plasma  memhrane  but  not  in  endo- 
plasmic  reticulum.  This  may  explain  why  other  investigators 
did  not  find  that  PKC  in  total  particulate  fraction  changed 
during choline deficiency (Singh et al., 1990). Our ohserva- 
tions of simultaneous accumulation of AAG, DAG, and in- 
creased  amount.  and  activation of PKC  suggests  that ,  in oiuo, 
accumulation of these  DRGs  perturhed  PKC  signal  transduc- 
tion. 
In order t,o assess whether functional changes consistent 
with  activation of P K C  were  present,  we  measured  glycogen 
synthase  activity  in  livers  from  animals  fed a choline-deficient 
diet. A t  1 week,  glycogen  synthase  activity  was lower  in 
the deficient (0.29 f 0 . 0 3  activity ratio) than in the control 
group  (0.49 k 0.04 activity  ratio).  Glycogen  synthase  contains 
multiple  sites  which  when  phosphorylated,  inactivate  the 
enzyme (Camici et a/., 1984a; Camici et al., 1984h: Iioach, 
1990). PKC  phosphorylates  and  inactivates  hepatic glycogen 
synthase (Ahmad et a/ . ,  1984: Roach, 1990). Thus, we have 
identified what we helieve is the  first dietary manipulation 
which influences hoth the amount and activity of I’KC iso- 
zymes  in  any  organ. 
There may he differences between receptor-mediated and 
choline  deficiency-mediated  activation of I’KC. Normally 
PKC that has heen activated during signal transrluction is 
rapidly degraded, leading to down-regulation. For example. 
this  occurs  after  treatment  with  phorbol  esters  (Castagna rt 
al., 1982).  However,  prolonged  activation of PKC by Dl<(; is 
not  always  associated  with  such  down-regulation  (1)iaz-Lav- 
iada et a/., 1990; Price et al., 1989). I t  is unclear  whether  the 
initial activation of PKC (Megidish and Mazurek, 1989) or 
the suhsequent down-regulation (Brooks v t  al., 1991 1 is the 
critical event in carcinogenesis. Choline deficiency could in- 
fluence PKC activity via mechanisms that do not involve 
accumulation of DRG.  Metaholites  generated  from some cho- 
line-cont,aining  phospholipids  (sphingosine  nnd  Ivsosphingo- 
lipids  from  sphingomyelin  and  lvsophosphatid~lcholine  from 
phosphatidylcholine) act as negative  effectors  motlulat  ing 
PKC  activation  (Hannun, 1989: Hannun  and Hell, 198% 1,nvie 
et ai., 1990; Merrill and Stevens, 1989). \Ye a r e  currently 
examining  changes  in  sphingosine,  ceramide,  sphingomyelin. 
and  phosphatidylserine  during  choline  deficiency.2 
We  suggest  that  the  accumulation of DRG and  suhsequent 
elevation of hepatic  PKC  protein  and  activity  during  choline 
deficiency is a critical  ahnormality  which  eventually  contrih- 
Utes to the  development of hepatic  cancer in these  animals. 
Several  lines of evidence  indicate  that  cancers  might  develop 
secondary  to  abnormalities  in  I’KC-mediated  signal  transduc- 
tion. The phorbol esters, potent mitogens, and tumor pro- 
moters are analogs of DRC (Nishizuka, 1986). Many other 
mitogens also activate PKC (Pessin et al., 1990: liozengurt, 
1986). Abnormalities in the expression of genes which are 
often associated with tumors can also he  associated  with 
alterations  in  DRG-  and  PKC-mediated  pathways  (Diaz- 
Laviada et a/ . ,  1990; Kato ef al., 1089: Price rt al.. 1989: 
Weinstein,  1990;  Wilkison et a/.,  1989;  b’olfman  and Macara. 
1987; Wolfman et al., 1987). Activated I’KC, in turn, may 
induce expression of the c-my oncogene (Kaihuchi  et al.. 
1986;  Rozengurt.  1986).  Indeed, c - m y  was  over  expressed in 
liver  and  tumor  tissue  from  choline  deficient rat liver (Chan-  
dar  et ai., 1989;  Hsieh et a/., 1989). Transfection of fihrohlasts 
with a gene  for  constantly  active  mutant  forms of PKC ( ( I  or 
p)  causes the cells to hecome transformed and tumorigenic 
(Krauss et al., 1989;  Megidish  and  Mazurek, 1989: Persons rt 
ai., 1988).  Rat  liver  epithelial  cells  which  constitutively  over 
express PKCI3I were  not  transformed  hut  did  overexpress  c- 
rnyc (Hsieh et al., 1989). Thus, many ohservntions suggest 
that  increased  DRG  concentration  with  subsequent  activat on 
of PKC  may  be a key  event  in  carcinogenesis.  Although  PKC- 
mediated  signal  transduction  has  heen  intensely  investigated, 
we do not know the precise link between activation o f  t h i s  
pathway  and  carcinogenesis.  It is noteworthy  that  the  isozyme 
which we observed  to  increase  most is I’KC 6.  Nuclear PKC‘ 
activit,y (probably the i, isozyme) in liver has heen recently 
characterized  (Rogue et al., 1990) and it phosphorylates  sev- 
eral  nuclear  proteins  (including DNA met hvlt ransferase  nnd 
K.-A. da Costa. S. C. Garner. and S. H. Zeisel. mnnuwripf in  
~ ~~ ~~~ 
preparation. 
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ADP-ribosyltransferase). Activation of PKC  also  modulates 
the  binding of proteins  to  cis-regulatory  elements  on  DNA 
which control gene expression (Hata et al., 1989). 
There  are several other  mechanisms which have  been  sug- 
gested for the cancer-promoting effect of a diet devoid of 
choline. In  the choline-deficient liver there  is a progressive 
increase  in cell death  and cell proliferation  (Chandar et al., 
1987; Chandar and Lombardi, 1988), consistent with the 
effects of prolonged activation of PKC. The associated in- 
creased  rate of DNA  synthesis could be  the  cause of greater 
sensitivity to chemical carcinogens (Ghoshal et al., 1983). 
Choline deficiency also affects  the genome. Hypomethylation 
of  DNA  (Dizik et al., 1991; Locker et al., 1986), abnormalities 
in DNA  repair  (Li  and  Randerath, 1990), and  DNA  damage 
caused by lipid  peroxides (Banni et al., 1990) could  contribute 
to   the initiating  events  leading  to carcinogenesis. 
It is interesting  that choline-deficient rats  not only have a 
higher incidence of spontaneous hepatocarcinoma but that 
they  are markedly sensitized  to  the effects of administered 
carcinogens (Newberne and Rogers, 1986). We suggest that 
perturbed  PKC  signal  transduction may lower the  threshold 
dose of carcinogen needed to initiate the development of 
cancers. The choline-deficient rat model could be used to 
elucidate  the  relationship between PKC  signaling  and  chem- 
ical  carcinogenesis. 
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